Use of this antifungal agent was associated with excess risk for spontaneous abortion and, at higher doses, for fetal cardiac defects.
Fluconazole is most commonly prescribed for vaginal yeast infections, which can be resolved with a single 150-mg dose. Higher doses are indicated for systemic fungal infections. To evaluate the safety of fluconazole during pregnancy, Canadian investigators conducted a nested case-control study in a cohort of 440,000 pregnant women who delivered in Quebec from 1998 through 2015. Fluconazole dosages were stratified into low (≤150 mg) or high (>150 mg).
Overall, <1% of women received fluconazole during pregnancy; of these, 70% received a single low dose. Compared with no fluconazole exposure, low-dose and high-dose exposure were associated with excess risk for spontaneous abortion (adjusted odds ratios, 2.2 and 3.2, respectively). High-dose flu…
Reviewing Author
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)